• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用热稳定的凝聚层基核壳纳米系统共递送信使核糖核酸和质粒脱氧核糖核酸

Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems.

作者信息

Nasr Sarah S, Lee Sangeun, Thiyagarajan Durairaj, Boese Annette, Loretz Brigitta, Lehr Claus-Michael

机构信息

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, 66123 Saarbrücken, Germany.

Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.

出版信息

Pharmaceutics. 2021 Nov 13;13(11):1924. doi: 10.3390/pharmaceutics13111924.

DOI:10.3390/pharmaceutics13111924
PMID:34834339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619316/
Abstract

Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA (mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of broad pharmaceutical application. A core-shell nanostructure is designed with a thermally stabilized gelatin-pDNA coacervate in its center. Thermal stabilization enhances the core's colloidal stability and pDNA shielding effect against nucleases as confirmed by nanoparticle tracking analysis and gel electrophoresis, respectively. The stabilized, pDNA-loaded core is coated with the cationic peptide protamine sulfate to enable additional surface-loading with mRNA. The dual-loaded core-shell system transfects murine dendritic cell line DC2.4 with both fluorescent reporter mRNA and pDNA simultaneously, showing a transfection efficiency of 61.4 ± 21.6% for mRNA and 37.6 ± 19.45% for pDNA, 48 h post-treatment, whereas established commercial, experimental, and clinical transfection reagents fail. Hence, the unique co-transfectional capacity and the negligible cytotoxicity of the reported system may hold prospects for vaccination among other downstream applications.

摘要

使用同一纳米载体共同递送不同种类的蛋白质编码多核苷酸,例如信使核糖核酸(mRNA)和质粒DNA(pDNA),是核酸递送领域中一个有趣但仍鲜少被研究的课题。因此,本研究旨在探索使用单一纳米载体同时递送mRNA(mCherry)和pDNA(pAmCyan)的可能性。后者基于A型明胶,这是一种具有广泛药物应用的生物相容性和可生物降解的生物聚合物。设计了一种核壳纳米结构,其中心为热稳定的明胶-pDNA凝聚层。热稳定性分别通过纳米颗粒跟踪分析和凝胶电泳得到证实,增强了核心的胶体稳定性和pDNA对核酸酶的屏蔽作用。稳定的、负载pDNA的核心用阳离子肽硫酸鱼精蛋白包被,以便能够额外在表面负载mRNA。双负载核壳系统能够同时用荧光报告mRNA和pDNA转染小鼠树突状细胞系DC2.4,在处理后48小时,mRNA的转染效率为61.4±21.6%,pDNA的转染效率为37.6±19.45%,而现有的商业、实验和临床转染试剂则无法做到。因此,所报道系统独特的共转染能力和可忽略不计的细胞毒性在其他下游应用中,可能为疫苗接种带来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/62b3cbd69443/pharmaceutics-13-01924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/8e35a5c545d1/pharmaceutics-13-01924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/b92d5946b426/pharmaceutics-13-01924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/706078bd2984/pharmaceutics-13-01924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/e5bf2019d40f/pharmaceutics-13-01924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/a505f9c8aa6e/pharmaceutics-13-01924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/5e0cf819579e/pharmaceutics-13-01924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/62b3cbd69443/pharmaceutics-13-01924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/8e35a5c545d1/pharmaceutics-13-01924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/b92d5946b426/pharmaceutics-13-01924-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/706078bd2984/pharmaceutics-13-01924-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/e5bf2019d40f/pharmaceutics-13-01924-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/a505f9c8aa6e/pharmaceutics-13-01924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/5e0cf819579e/pharmaceutics-13-01924-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7394/8619316/62b3cbd69443/pharmaceutics-13-01924-g007.jpg

相似文献

1
Co-Delivery of mRNA and pDNA Using Thermally Stabilized Coacervate-Based Core-Shell Nanosystems.使用热稳定的凝聚层基核壳纳米系统共递送信使核糖核酸和质粒脱氧核糖核酸
Pharmaceutics. 2021 Nov 13;13(11):1924. doi: 10.3390/pharmaceutics13111924.
2
Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier.通过在单个纳米载体上共同递送信使核糖核酸和质粒脱氧核糖核酸实现核酸编码蛋白质的时间交错表达。
Drug Deliv Transl Res. 2024 Dec;14(12):3339-3353. doi: 10.1007/s13346-024-01668-w. Epub 2024 Jul 15.
3
Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.用于短发夹RNA编码质粒双靶向递送的逆-反向d-肽修饰透明质酸/生物可还原超支化聚(酰胺胺)/pDNA核壳三元纳米颗粒
Acta Biomater. 2017 Jul 15;57:156-169. doi: 10.1016/j.actbio.2017.04.024. Epub 2017 Apr 22.
4
Polyethylenimine-based amphiphilic core-shell nanoparticles: study of gene delivery and intracellular trafficking.基于聚亚乙基亚胺的两亲性核壳纳米粒子:基因传递和细胞内转运研究。
Biointerphases. 2012 Dec;7(1-4):16. doi: 10.1007/s13758-011-0016-4. Epub 2012 Feb 9.
5
Well-defined star polymers for co-delivery of plasmid DNA and imiquimod to dendritic cells.用于将质粒DNA和咪喹莫特共递送至树突状细胞的明确的星形聚合物。
Acta Biomater. 2017 Jan 15;48:378-389. doi: 10.1016/j.actbio.2016.10.038. Epub 2016 Oct 27.
6
Complex Coacervation-Integrated Hybrid Nanoparticles Increasing Plasmid DNA Delivery Efficiency in Vivo.复杂共凝聚体整合的混合纳米粒子提高体内质粒 DNA 递送效率。
ACS Appl Mater Interfaces. 2016 Nov 16;8(45):30735-30746. doi: 10.1021/acsami.6b10306. Epub 2016 Nov 7.
7
Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.聚(D,L-丙交酯-共-乙交酯)载聚酰胺-胺-质粒 DNA 树枝状聚合物复合物纳米粒的制备、表征及体外评价及其在非病毒基因传递中的应用。
J Pharm Sci. 2010 Jan;99(1):368-84. doi: 10.1002/jps.21840.
8
Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.可生物降解微球的合理设计、制备、表征和体外测试,该微球可在 HepG2 肝细胞中产生靶向和持续的转基因表达。
J Drug Target. 2011 Jul;19(6):393-408. doi: 10.3109/1061186X.2010.504263. Epub 2010 Aug 3.
9
PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA.聚乙二醇化可改善信使 RNA 纳米颗粒的形成和转染效率。
Pharm Res. 2011 Sep;28(9):2223-32. doi: 10.1007/s11095-011-0464-z. Epub 2011 May 19.
10
Plasmid DNA cationic non-viral vector complexes induce cytotoxicity-associated PD-L1 expression up-regulation in cancer cells in vitro.质粒DNA阳离子非病毒载体复合物在体外可诱导癌细胞中与细胞毒性相关的PD-L1表达上调。
Int J Pharm. 2023 Jan 25;631:122481. doi: 10.1016/j.ijpharm.2022.122481. Epub 2022 Dec 10.

引用本文的文献

1
Smart coacervate microdroplets: biomimetic design, material innovations, and emerging applications in biomacromolecule delivery.智能凝聚微滴:仿生设计、材料创新及在生物大分子递送中的新兴应用
Bioact Mater. 2025 Jun 10;52:244-270. doi: 10.1016/j.bioactmat.2025.06.016. eCollection 2025 Oct.
2
Macromolecular Polymer Based Complexes: A Diverse Strategy for the Delivery of Nucleotides.基于高分子聚合物的复合物:核苷酸传递的多样化策略。
Protein Pept Lett. 2024;31(8):586-601. doi: 10.2174/0109298665310091240809103048.
3
Realizing time-staggered expression of nucleic acid-encoded proteins by co-delivery of messenger RNA and plasmid DNA on a single nanocarrier.

本文引用的文献

1
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models.局部递送编码细胞因子的 mRNA 可促进多种临床前肿瘤模型中的抗肿瘤免疫和肿瘤消除。
Sci Transl Med. 2021 Sep 8;13(610):eabc7804. doi: 10.1126/scitranslmed.abc7804.
2
Nucleic acid delivery for therapeutic applications.治疗应用的核酸递送。
Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4.
3
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
通过在单个纳米载体上共同递送信使核糖核酸和质粒脱氧核糖核酸实现核酸编码蛋白质的时间交错表达。
Drug Deliv Transl Res. 2024 Dec;14(12):3339-3353. doi: 10.1007/s13346-024-01668-w. Epub 2024 Jul 15.
4
The use of RNA-based treatments in the field of cancer immunotherapy.基于 RNA 的治疗方法在癌症免疫治疗领域的应用。
Mol Cancer. 2023 Jul 7;22(1):106. doi: 10.1186/s12943-023-01807-w.
5
Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review.源自动物、植物和微生物的天然高分子复合材料在疫苗递送和佐剂应用中的研究进展综述
Gels. 2023 Mar 15;9(3):227. doi: 10.3390/gels9030227.
6
Peptide-based coacervates in therapeutic applications.基于肽的凝聚物在治疗应用中的研究
Front Bioeng Biotechnol. 2023 Jan 4;10:1100365. doi: 10.3389/fbioe.2022.1100365. eCollection 2022.
7
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies.基于聚合物和脂质的 siRNA 纳米颗粒的表面设计选择:使用抗体。
Int J Mol Sci. 2022 Nov 11;23(22):13929. doi: 10.3390/ijms232213929.
8
Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies.用于先进疗法的质粒DNA和信使RNA递送系统
Pharmaceutics. 2022 Apr 7;14(4):810. doi: 10.3390/pharmaceutics14040810.
控制常规和自我扩增 mRNA 疗法固有免疫活性的策略:传递信息。
Adv Drug Deliv Rev. 2021 Sep;176:113900. doi: 10.1016/j.addr.2021.113900. Epub 2021 Jul 26.
4
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.mRNA-脂质纳米颗粒 COVID-19 疫苗:结构与稳定性。
Int J Pharm. 2021 May 15;601:120586. doi: 10.1016/j.ijpharm.2021.120586. Epub 2021 Apr 9.
5
Strategies for simultaneous and successive delivery of RNA.RNA 的同步和连续递呈策略。
J Mol Med (Berl). 2020 Dec;98(12):1767-1779. doi: 10.1007/s00109-020-01956-1. Epub 2020 Nov 4.
6
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.COVID-19 疫苗领跑者及其纳米技术设计。
ACS Nano. 2020 Oct 27;14(10):12522-12537. doi: 10.1021/acsnano.0c07197. Epub 2020 Oct 9.
7
Helix-coil transition of gelatin: helical morphology and stability.明胶的螺旋-卷曲转变:螺旋形态与稳定性
Soft Matter. 2008 Feb 21;4(3):544-549. doi: 10.1039/b713075a.
8
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma.三重混合与肿瘤抗原 mRNA 电穿孔树突状细胞疫苗接种联合伊匹单抗:晚期黑色素瘤中 T 细胞激活与临床应答之间的联系。
J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000329.
9
The promise of mRNA vaccines: a biotech and industrial perspective.mRNA疫苗的前景:生物技术与产业视角
NPJ Vaccines. 2020 Feb 4;5:11. doi: 10.1038/s41541-020-0159-8. eCollection 2020.
10
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response.定制 mRNA 疫苗以平衡固有/适应性免疫反应。
Trends Mol Med. 2020 Mar;26(3):311-323. doi: 10.1016/j.molmed.2019.10.002. Epub 2019 Nov 5.